Skip to main content

Alcohol Consumption

0
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
2 programs
SBIRT Training & Support ToolN/A1 trial
Single-session alcohol interventionN/A1 trial
Active Trials
NCT02489032Completed330Est. Nov 2016
NCT02895984Completed1,424Est. Oct 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Oregon TherapeuticsSingle-session alcohol intervention
Oregon TherapeuticsSBIRT Training & Support Tool

Clinical Trials (2)

Total enrollment: 1,754 patients across 2 trials

NCT02895984Oregon TherapeuticsSingle-session alcohol intervention

Reducing Hazardous Alcohol Use in Social Networks Using Targeted Intervention

Start: Aug 2016Est. completion: Oct 20171,424 patients
N/ACompleted
NCT02489032Oregon TherapeuticsSBIRT Training & Support Tool

Web-Based Training for EAP Alcohol Screening, Brief Intervention, and Refer

Start: Jun 2016Est. completion: Nov 2016330 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.